Publisher： Bentham Science Publishers
E-ISSN： 1875-676x|3|3|195-204
ISSN： 1573-4129
Source： Current Pharmaceutical Analysis, Vol.3, Iss.3, 2007-08, pp. : 195-204
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Natriuretic peptides (NPs) are endogenous low molecular weight peptides known for their hypotensive activities. Due to their ability to induce both natriuresis (Na+ secretion) and diuresis, in fact, these peptides can profoundly decrease the body haemodynamic load, an effect which represents a main goal for all therapies aiming at improving the health of those subjects affected by different forms of heart and kidney failure. Over the years, many evidences have been provided for the involvement of NPs in the control of different cardiovascular parameters both in physiological and pathological conditions. This has led many researchers to test the possible therapeutic effects of different NPs and the pharmacological industries to develop exogenous NPs forms with a higher activity. This review aims then at summarizing the current knowledge about the therapeutic and clinical applications of NPs, also considering “atypical” NPs and the problems yet to be solved.
Related content
Natriuretic peptides as therapeutic targets
Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 2, 2006-04 ,pp. :
Access to resources
Recommend
Natriuretic Peptides: Future Use?
Heart Drug, Vol. 2, Iss. 1, 2002-04 ,pp. :
Natriuretic Peptides in Septic Patients
Current Medicinal Chemistry, Vol. 16, Iss. 30, 2009-10 ,pp. :
Nicorandil – Review of Pharmacological Properties and Clinical Applications
Heart Drug, Vol. 5, Iss. 4, 2005-12 ,pp. :
Pharmacological Characteristics and Clinical Applications of K201
Current Clinical Pharmacology, Vol. 4, Iss. 2, 2009-05 ,pp. :